Form HLTH5477 Special Authority Request - Elbasvir Plus Grazoprevir With or Without Ribavirin (Rbv) for Chronic Hepatitis C - British Columbia, Canada

Form HLTH5477 Special Authority Request - Elbasvir Plus Grazoprevir With or Without Ribavirin (Rbv) for Chronic Hepatitis C - British Columbia, Canada is used for requesting special authority for the use of the medication Elbasvir Plus Grazoprevir for the treatment of Chronic Hepatitis C in British Columbia, Canada.

The form HLTH5477 Special Authority Request - Elbasvir Plus Grazoprevir With or Without Ribavirin (Rbv) for Chronic Hepatitis C in British Columbia, Canada is generally filed by healthcare providers or physicians on behalf of their patients.

FAQ

Q: What is the purpose of Form HLTH5477?
A: Form HLTH5477 is used to request special authority for the use of Elbasvir Plus Grazoprevir With or Without Ribavirin (Rbv) for Chronic Hepatitis C in British Columbia, Canada.

Q: What is Elbasvir Plus Grazoprevir?
A: Elbasvir Plus Grazoprevir is a medication used to treat Chronic Hepatitis C.

Q: Is special authority required for the use of Elbasvir Plus Grazoprevir in British Columbia?
A: Yes, special authority is required to access Elbasvir Plus Grazoprevir for the treatment of Chronic Hepatitis C in British Columbia.

Q: Can Elbasvir Plus Grazoprevir be used with or without Ribavirin?
A: Yes, Elbasvir Plus Grazoprevir can be used with or without Ribavirin depending on the specific circumstances and treatment plan.